North America Low Molecular Weight Heparin Market
The North America Low Molecular Weight Heparin Market size was valued at US$ 1,232.86 Mn in 2021 and is projected to reach US$ 1,963.46 Mn by 2028, growing at a CAGR of 6.9% during 2021 - 2028.
Report Coverage
- Product Type: Enoxaparin, Dalteparin, Tinzaparin, Fraxiparine, Nadroparin
- Packaging: Multi-Vials and Prefilled Syringes
- Application: Deep Vein Thrombosis, Acute Coronary Syndrome, Pulmonary Embolism
- End User: Hospitals, Clinics, Ambulatory Surgical Centers
US$ 1,232.86 Mn
Market size in 2021
US$ 1,963.46 Mn
Market Size by 2028
6.9%
CAGR, 2021 - 2028
2022-2028
Forecast Period
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. North America Low Molecular Weight Heparin Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. North America Low Molecular Weight Heparin Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. North America Low Molecular Weight Heparin Market Regional Analysis
6.2 North America Low Molecular Weight Heparin Market Revenue 2019-2028 (US$ Million)
6.3 North America Low Molecular Weight Heparin Market Forecast Analysis
7. North America Low Molecular Weight Heparin Market Analysis – by Product Type
7.1 Enoxaparin
- 7.1.1 Overview
- 7.1.2 Enoxaparin: North America Low Molecular Weight Heparin Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.2 Dalteparin
- 7.2.1 Overview
- 7.2.2 Dalteparin: North America Low Molecular Weight Heparin Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.3 Tinzaparin
- 7.3.1 Overview
- 7.3.2 Tinzaparin: North America Low Molecular Weight Heparin Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.4 Fraxiparine
- 7.4.1 Overview
- 7.4.2 Fraxiparine: North America Low Molecular Weight Heparin Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.5 Nadroparin
- 7.5.1 Overview
- 7.5.2 Nadroparin: North America Low Molecular Weight Heparin Market – Revenue and Forecast, 2019-2028 (US$ Million)
8. North America Low Molecular Weight Heparin Market Analysis – by Packaging
8.1 Multi-Vials and Prefilled Syringes
- 8.1.1 Overview
- 8.1.2 Multi-Vials and Prefilled Syringes: North America Low Molecular Weight Heparin Market – Revenue and Forecast, 2019-2028 (US$ Million)
9. North America Low Molecular Weight Heparin Market Analysis – by Application
9.1 Deep Vein Thrombosis
- 9.1.1 Overview
- 9.1.2 Deep Vein Thrombosis: North America Low Molecular Weight Heparin Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.2 Acute Coronary Syndrome
- 9.2.1 Overview
- 9.2.2 Acute Coronary Syndrome: North America Low Molecular Weight Heparin Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.3 Pulmonary Embolism
- 9.3.1 Overview
- 9.3.2 Pulmonary Embolism: North America Low Molecular Weight Heparin Market – Revenue and Forecast, 2019-2028 (US$ Million)
10. North America Low Molecular Weight Heparin Market Analysis – by End User
10.1 Hospitals
- 10.1.1 Overview
- 10.1.2 Hospitals: North America Low Molecular Weight Heparin Market – Revenue and Forecast, 2019-2028 (US$ Million)
10.2 Clinics
- 10.2.1 Overview
- 10.2.2 Clinics: North America Low Molecular Weight Heparin Market – Revenue and Forecast, 2019-2028 (US$ Million)
10.3 Ambulatory Surgical Centers
- 10.3.1 Overview
- 10.3.2 Ambulatory Surgical Centers: North America Low Molecular Weight Heparin Market – Revenue and Forecast, 2019-2028 (US$ Million)
11. North America Low Molecular Weight Heparin Market – North America Analysis
11.1 Overview
11.2 North America- 11.2.1 North America Low Molecular Weight Heparin Market Breakdown, by Key Country, 2022 and 2028 (%)
- 11.2.1.1 North America Low Molecular Weight Heparin Market – Revenue and Forecast Analysis – by Country
- 11.2.1.1 US: North America Low Molecular Weight Heparin Market – Revenue and Forecast to 2028 (US$ Million)
- 11.2.1.1.1 US: North America Low Molecular Weight Heparin Market Breakdown, by Product Type
- 11.2.1.1.2 US: North America Low Molecular Weight Heparin Market Breakdown, by Packaging
- 11.2.1.1.3 US: North America Low Molecular Weight Heparin Market Breakdown, by Application
- 11.2.1.1.4 US: North America Low Molecular Weight Heparin Market Breakdown, by End User
- 11.2.1.2 Canada: North America Low Molecular Weight Heparin Market – Revenue and Forecast to 2028 (US$ Million)
- 11.2.1.2.1 Canada: North America Low Molecular Weight Heparin Market Breakdown, by Product Type
- 11.2.1.2.2 Canada: North America Low Molecular Weight Heparin Market Breakdown, by Packaging
- 11.2.1.2.3 Canada: North America Low Molecular Weight Heparin Market Breakdown, by Application
- 11.2.1.2.4 Canada: North America Low Molecular Weight Heparin Market Breakdown, by End User
- 11.2.1.3 Mexico : North America Low Molecular Weight Heparin Market – Revenue and Forecast to 2028 (US$ Million)
- 11.2.1.3.1 Mexico : North America Low Molecular Weight Heparin Market Breakdown, by Product Type
- 11.2.1.3.2 Mexico : North America Low Molecular Weight Heparin Market Breakdown, by Packaging
- 11.2.1.3.3 Mexico : North America Low Molecular Weight Heparin Market Breakdown, by Application
- 11.2.1.3.4 Mexico : North America Low Molecular Weight Heparin Market Breakdown, by End User
12. Competitive Landscape
12.1 Heat Map Analysis
12.2 Company Positioning and Concentration
13. Industry Landscape
13.1 Overview
13.2 Market Initiative
13.3 Partnerships and Collaborations
13.4 Other Developments
14. Company Profiles
14.1 Abbott
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 Aspen Holdings
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 B. Braun Medical Inc.
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 Dr. Reddy's Laboratories
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 LEO Pharma A/S
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 Novartis
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 Pfizer Inc.
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
14.8 Sanofi
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
14.9 TEVA PHARMACEUTICAL INDUSTRIES LTD
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments
15. Appendix
15.1 About Business Market Insights
15.2 List of Abbreviations
Access the Full N Market Report
Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.
